Home > Food and Beverages > Nutraceuticals > apigenin market
Get a free sample of Apigenin Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Apigenin Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Notable players in the apigenin market are :
These companies are actively engaged in the production, distribution, and research of apigenin, positioning themselves as leading contributors to the market.
Apigenin market revenue from pharma & healthcare segment exceeded USD 127.2 thousand in 2022 and will reach USD 191.2 thousand by 2032, as the product is extensively utilized for its potential therapeutic properties, including its antioxidant, anti-inflammatory, anticancer, neuroprotective, and antimicrobial effects.
The market size of apigenin was valued at around USD 300 Thousand in 2022 and is estimated to surpass USD 435.5 Thousand by 2032, backed by the potential health benefits and therapeutic properties of the product which favors its demand across pharmaceuticals, cosmetics, and food & beverages sectors.
North America marker for apigenin crossed USD 144.1 thousand in 2022 and is expected to reach USD 209.7 thousand by 2032, owing to the consumer preference for natural ingredients, and a rising demand for plant-based ingredients in various industries, including pharmaceuticals, nutraceuticals, and cosmetics.
Indofine Chemical Company Inc., Cayman Chemical Company, TCI Chemicals, Sigma-Aldrich (Merck KGaA), ChemFaces, and Extrasynthese.